Manuscripts
Showing 1591 manuscripts.
Simple Pediatric AIDS Severity Score (PASS): a pediatric severity score for resource-limited settings.
Citation
Kunjal Patel, D.Sc., M.P.H., Geoffrey A. Weinberg, M.D., Kate Buchacz, Ph.D., Kenneth McIntosh, M.D., Wayne M. Dankner, M.D., George Seage, III, Sc.D., M.P.H. Simple Pediatric AIDS Severity Score (PASS): a pediatric severity score for resource-limited settings. Journal of Acquired Immune Deficiency Syndromes. 2006 Dec 15; 43(5):611 - 617. PMID: 17003691.Year
2006
Journal
Journal of Acquired Immune Deficiency Syndromes
Neuropsychiatric complications of antiretroviral therapy
Citation
Michelle S. Cespedes, M.D., Judith A. Aberg, M.D. Neuropsychiatric complications of antiretroviral therapy. Drug Safety. 2006 Oct 01; 29(10):865-74.Year
2006
Journal
Drug Safety
Changes in the slope of the CD4 cell count increase after initiation of potent antiretroviral treatment
Citation
Ronald J. Bosch, Ph.D., Rui Wang, M.S., Florin Vaida, Ph.D., Michael M. Lederman, M.D., Mary Albrecht, M.D. Changes in the slope of the CD4 cell count increase after initiation of potent antiretroviral treatment. Journal of Acquired Immune Deficiency Syndromes. 2006 Dec 01; 43(4):433-5.Year
2006
Journal
Journal of Acquired Immune Deficiency Syndromes
Activity of newer triazoles against histoplasma capsulatum from patients with AIDS who failed fluconazole
Citation
L. Joseph Wheat, M.D., Patricia A. Connolly, M.S., Melinda L. Smedema, Michelle M. Durkin, Edward Brizendine, Paul Mann, Reena Patel, Paul McNicholas, Mitchell (Mitch) Goldman, M.D. Activity of newer triazoles against histoplasma capsulatum from patients with AIDS who failed fluconazole. Journal of Antimicrobial Chemotherapy. 2006 Jun 01; 57(6):1235-9. PMID: 16627592.Year
2006
Journal
Journal of Antimicrobial Chemotherapy
Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS clinical trials group A5138
Citation
Michael M. Lederman, M.D., Laura Smeaton, M.S., Kimberly Y. Smith, M.D., M.P.H., Benigno Rodriguez, M.D., Minya Pu, M.A., Hongying Wang, M.S., Anne Sevin, Ph.D., Pablo Tebas, M.D., Scott F. Sieg, Ph.D., Kathleen A. Medvik, B.S., M.T. (A.S.C.P.), David M. Margolis, M.D., Richard B. Pollard, M.D., Hildegund Ertl, Hernan Valdez, M.D. Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS clinical trials group A5138. Journal of Infectious Diseases. 2006 Dec 15; 194(12):1677-85.Year
2006
Journal
Journal of Infectious Diseases
Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy
Citation
David Alain Wohl, M.D., Grace McComsey, M.D., Pablo Tebas, M.D., Todd T. Brown, M.D., Marshall Jay Glesby, M.D., Ph.D., Dominic N. Reeds, M.D., Cecilia M. Shikuma, M.D., Kathleen Mulligan, Ph.D., Michael P. Dube, M.D., David A. Wininger, M.D., Jeannie S. Huang, M.D., M.P.H., Manuel Revuelta, M.D., Judith Silverstein Currier, M.D., M.Sc., Susan Swindells, M.B.B.S., Carl J. Fichtenbaum, M.D., Michael T. Basar, B.S., Marisa T. Tungsiripat, M.D., William A. Meyer, III, Ph.D., James Weihe, M.D., Christine Wanke, M.D. Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. Clinical Infectious Diseases. 2006 Sep 01; 43(5):645-53.Year
2006
Journal
Clinical Infectious Diseases
A reliable and inexpensive EasyCD4 assay for monitoring HIV-infected individuals in resource-limited settings
Citation
Pachamuthu (Bala) Balakrishnan, Ph.D., Suniti (Daralak) Solomon, M.D., J. Mohanakrishnan, Anitha J. Cecelia, M.Sc., Nagalingeshwaran Kumarasamy, M.B.B.S., Ph.D., K. G. Murugavel, B. Venkatakrishnan, S. S. Solomon, S. M. Crowe, Aylur Kailasam Ganesh, A.C.A., B. Com., S. P. Thyagarajan, Timothy P. Flanigan, M.D., Kenneth H. Mayer, M.D. A reliable and inexpensive EasyCD4 assay for monitoring HIV-infected individuals in resource-limited settings. Journal of Acquired Immune Deficiency Syndromes. 2006 Sep 01; 43(1):23-6.Year
2006
Journal
Journal of Acquired Immune Deficiency Syndromes
Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384
Citation
Rajesh Gandhi, M.D., John Spritzler, Sc.D., Ellen Chan, M.Sc., David M. Asmuth, M.D., Benigno Rodriguez, M.D., Thomas C. Merigan, Jr., M.D., Martin S. Hirsch, M.D., Robert Shafer, M.D., Gregory K. Robbins, M.D., M.P.H., Richard B. Pollard, M.D. Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. Journal of Acquired Immune Deficiency Syndromes. 2006 Aug 01; 42(4):426-34.Year
2006
Journal
Journal of Acquired Immune Deficiency Syndromes
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy
Citation
Giovanni Schifitto, M.D., Constantin Yiannoutsos, Ph.D., David M. Simpson, M.D., Christina M. Marra, M.D., Elyse J. Singer, M.D., Dennis Kolson, M.D., Ph.D., Avindra Nath, M.D., Joseph R. Berger, M.D., Bradford A. Navia, M.D. A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. Journal of Neurovirology. 2006 Aug 01; 12(4):328-31. PMID: 16966223.Year
2006
Journal
Journal of Neurovirology
Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study
Citation
Alison A. Motsinger, Marylyn D. Ritchie, Ph.D., Robert Shafer, M.D., Gregory K. Robbins, M.D., M.P.H., Gene D. Morse, Pharm.D., Line Labbe, Ph.D., Grant R Wilkinson, Ph.D., D.Sc., David B. Clifford, M.D., Richard T. D'Aquila, M.D., Victoria A. Johnson, M.D., Richard B. Pollard, M.D., Thomas C. Merigan, Jr., M.D., Martin S. Hirsch, M.D., John P. Donahue, Richard B. Kim, M.D., David W. Haas, M.D. Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study. Pharmacogenetics and Genomics. 2006 Nov 01; 16(11):837-45.Year
2006
Journal
Pharmacogenetics and Genomics